Cargando…

Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities

Hürthle cell carcinoma (HCC) is a rare type of thyroid cancer with high rates of distant metastasis and recurrence. Along with the scarcity of effective systemic therapies for HCC, these factors contribute to poor clinical outcomes. The immunologic features of HCC are poorly defined and response rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganly, Ian, Kuo, Fengshen, Makarov, Vladimir, Dong, Yiyu, Ghossein, Ronald, Xu, Bin, Morris, Luc G.T., Chan, Timothy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389111/
https://www.ncbi.nlm.nih.gov/pubmed/37529400
http://dx.doi.org/10.1158/2767-9764.CRC-23-0120
_version_ 1785082227135086592
author Ganly, Ian
Kuo, Fengshen
Makarov, Vladimir
Dong, Yiyu
Ghossein, Ronald
Xu, Bin
Morris, Luc G.T.
Chan, Timothy A.
author_facet Ganly, Ian
Kuo, Fengshen
Makarov, Vladimir
Dong, Yiyu
Ghossein, Ronald
Xu, Bin
Morris, Luc G.T.
Chan, Timothy A.
author_sort Ganly, Ian
collection PubMed
description Hürthle cell carcinoma (HCC) is a rare type of thyroid cancer with high rates of distant metastasis and recurrence. Along with the scarcity of effective systemic therapies for HCC, these factors contribute to poor clinical outcomes. The immunologic features of HCC are poorly defined and response rates with immune checkpoint blockade have not been reported. A more comprehensive understanding of the immune landscape and factors that predict response to checkpoint inhibitors is needed. We performed RNA sequencing on 40 tumors to characterize the neoantigen landscape and immune microenvironment of HCC. We analyzed transcriptomic profiles, tumor-infiltrating immune cell populations, and measures of T-cell activation/dysfunction and correlated these to genetic features such as tumor mutation burden, neoantigen burden, mitochondrial mutations, and LOH from chromosomal uniparental disomy. Finally, immune profiles of patients with recurrence were compared with those of patients without recurrence. HCC tumors exhibited low levels of immune infiltration, with the more aggressive widely invasive phenotype associated with more immune depletion. There was a negative correlation between tumor mutation burden, neoantigen burden, programmed cell death ligand 1 (PD-L1) expression, and the immune infiltration score. HCC tumors that exhibited a global LOH from chromosomal uniparental disomy or haploidization had the lowest level of immune infiltration. HCC tumors that recurred displayed an immune-depleted microenvironment associated with global LOH and aerobic glycolysis. These findings offer new insights into the functional immune landscapes and immune microenvironment of HCC. Our data identify potential immunologic vulnerabilities for these understudied and often fatal cancers. SIGNIFICANCE: The immune landscape of HCC is poorly defined and response rates to immunotherapy have not been reported. The authors found the immune microenvironment in HCC to be depleted. This immunosuppression is associated with a global LOH from haploidization and uniparental disomy, resulting in whole chromosome losses across the genome.
format Online
Article
Text
id pubmed-10389111
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for Cancer Research
record_format MEDLINE/PubMed
spelling pubmed-103891112023-08-01 Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities Ganly, Ian Kuo, Fengshen Makarov, Vladimir Dong, Yiyu Ghossein, Ronald Xu, Bin Morris, Luc G.T. Chan, Timothy A. Cancer Res Commun Research Article Hürthle cell carcinoma (HCC) is a rare type of thyroid cancer with high rates of distant metastasis and recurrence. Along with the scarcity of effective systemic therapies for HCC, these factors contribute to poor clinical outcomes. The immunologic features of HCC are poorly defined and response rates with immune checkpoint blockade have not been reported. A more comprehensive understanding of the immune landscape and factors that predict response to checkpoint inhibitors is needed. We performed RNA sequencing on 40 tumors to characterize the neoantigen landscape and immune microenvironment of HCC. We analyzed transcriptomic profiles, tumor-infiltrating immune cell populations, and measures of T-cell activation/dysfunction and correlated these to genetic features such as tumor mutation burden, neoantigen burden, mitochondrial mutations, and LOH from chromosomal uniparental disomy. Finally, immune profiles of patients with recurrence were compared with those of patients without recurrence. HCC tumors exhibited low levels of immune infiltration, with the more aggressive widely invasive phenotype associated with more immune depletion. There was a negative correlation between tumor mutation burden, neoantigen burden, programmed cell death ligand 1 (PD-L1) expression, and the immune infiltration score. HCC tumors that exhibited a global LOH from chromosomal uniparental disomy or haploidization had the lowest level of immune infiltration. HCC tumors that recurred displayed an immune-depleted microenvironment associated with global LOH and aerobic glycolysis. These findings offer new insights into the functional immune landscapes and immune microenvironment of HCC. Our data identify potential immunologic vulnerabilities for these understudied and often fatal cancers. SIGNIFICANCE: The immune landscape of HCC is poorly defined and response rates to immunotherapy have not been reported. The authors found the immune microenvironment in HCC to be depleted. This immunosuppression is associated with a global LOH from haploidization and uniparental disomy, resulting in whole chromosome losses across the genome. American Association for Cancer Research 2023-07-31 /pmc/articles/PMC10389111/ /pubmed/37529400 http://dx.doi.org/10.1158/2767-9764.CRC-23-0120 Text en © 2023 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by/4.0/This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
spellingShingle Research Article
Ganly, Ian
Kuo, Fengshen
Makarov, Vladimir
Dong, Yiyu
Ghossein, Ronald
Xu, Bin
Morris, Luc G.T.
Chan, Timothy A.
Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities
title Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities
title_full Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities
title_fullStr Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities
title_full_unstemmed Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities
title_short Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities
title_sort characterizing the immune microenvironment and neoantigen landscape of hürthle cell carcinoma to identify potential immunologic vulnerabilities
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389111/
https://www.ncbi.nlm.nih.gov/pubmed/37529400
http://dx.doi.org/10.1158/2767-9764.CRC-23-0120
work_keys_str_mv AT ganlyian characterizingtheimmunemicroenvironmentandneoantigenlandscapeofhurthlecellcarcinomatoidentifypotentialimmunologicvulnerabilities
AT kuofengshen characterizingtheimmunemicroenvironmentandneoantigenlandscapeofhurthlecellcarcinomatoidentifypotentialimmunologicvulnerabilities
AT makarovvladimir characterizingtheimmunemicroenvironmentandneoantigenlandscapeofhurthlecellcarcinomatoidentifypotentialimmunologicvulnerabilities
AT dongyiyu characterizingtheimmunemicroenvironmentandneoantigenlandscapeofhurthlecellcarcinomatoidentifypotentialimmunologicvulnerabilities
AT ghosseinronald characterizingtheimmunemicroenvironmentandneoantigenlandscapeofhurthlecellcarcinomatoidentifypotentialimmunologicvulnerabilities
AT xubin characterizingtheimmunemicroenvironmentandneoantigenlandscapeofhurthlecellcarcinomatoidentifypotentialimmunologicvulnerabilities
AT morrislucgt characterizingtheimmunemicroenvironmentandneoantigenlandscapeofhurthlecellcarcinomatoidentifypotentialimmunologicvulnerabilities
AT chantimothya characterizingtheimmunemicroenvironmentandneoantigenlandscapeofhurthlecellcarcinomatoidentifypotentialimmunologicvulnerabilities